High-Output Ileostomy on Postoperative Day Five
Ms. L is 62, postoperative day 5 after total colectomy with end ileostomy for fulminant colitis. The stoma is pink, moist, and functioning. Output has risen to 1,800 mL over 24 hours and is watery. Serum creatinine is 1.3 (baseline 0.8), potassium 3.2, magnesium 1.5. She reports cramping that precedes each output, no nausea, and a soft abdomen. She is on IV piperacillin-tazobactam, metoprolol, apixaban, and pantoprazole. The night nurse gave two doses of magnesium oxide. The surgeon asks you whether to start loperamide and whether the patient can be switched to oral medications.
1. Before any loperamide, what must be excluded? Use the data in the scenario.
Read the worked answer
First, look at what was given. Her magnesium was 1.5 and the night nurse gave magnesium oxide twice. Magnesium salts are osmotic laxatives; two doses can produce exactly 1,800 mL of watery output with cramping. That is a drug effect, not high-output ileostomy, and it is reversible. Stopping it is the first intervention, and repletion should use a non-laxative route or salt.
Second, exclude the dangerous causes before suppressing motility:
- Obstruction or stenosis - cramping before output is a warning. Check for a tight stoma, a snug fascial opening, and distension. Loperamide given in obstruction risks perforation.
- Sepsis or enteritis - she is on broad-spectrum antibiotics after fulminant colitis, so C. difficile is plausible. Fever, rising white count, or a change in abdominal exam change the plan entirely.
- Normal postoperative adaptation - at day 5, output of 1,000–1,500 mL is common; 1,800 mL is above expected but not automatically pathologic.
Reassuring features: soft abdomen, no nausea, pink moist stoma, functioning. I would still ask for a direct stoma and abdominal exam, stool testing if anything changes, and a strict 24-hour measured output chart before any antimotility drug is written.
2. Infection and obstruction are excluded. Write the output and electrolyte plan.
Read the worked answer
- Fluids: restrict hypotonic free water. Use an oral rehydration solution rather than water, tea, or juice, which pull sodium into the gut and increase output. Small, frequent, measured sips.
- Antimotility: loperamide 4 mg initially, then 2 mg after each loose output, titrated, commonly up to 16 mg/day, given 30 minutes before meals. Add a proton pump inhibitor to reduce gastric secretion if output stays high; octreotide if the combination fails.
- Electrolytes: potassium 3.2 and magnesium 1.5 both need replacement, but not with oral magnesium oxide - that is what caused this. Also remember that hypokalemia will not correct while magnesium stays low.
- Monitoring: daily weight, strict intake and output, urine output, orthostatic vitals, and repeat creatinine - it has already risen from 0.8 to 1.3, which says she is losing more than she is taking in.
- Education: she needs the counterintuitive lesson that drinking more plain water worsens ileostomy output. Hydration means sodium-containing fluid, not volume alone.
I would also make sure the ostomy is measured and the pouch fits, because a leaking pouch under a fresh laparotomy incision is its own problem.
3. The team wants to switch her to oral medications. What do you flag?
Read the worked answer
She has no colon and fast small-bowel transit. The governing rule: avoid extended-release and enteric-coated products. Their coatings are designed to dissolve at colonic pH or release over 12–24 hours; with an ileostomy they may pass intact or release unpredictably.
- Apixaban: immediate-release and absorbed proximally, generally acceptable - but it is an anticoagulant, and reduced exposure from rapid transit is not a trivial risk. Flag it to pharmacy and watch clinically.
- Metoprolol: tartrate (immediate release) is fine; succinate (extended release) is not reliable - specify the formulation explicitly on the order.
- Pantoprazole: enteric-coated granules. The capsule may be opened and the granules swallowed with applesauce, never crushed. Confirm with pharmacy.
- Timing: absorption is worst during peak output, so note the output volume around doses.
The IV-to-oral transition is exactly where these errors cluster, so I would ask for a full pharmacist review before discharge rather than flagging one drug at a time. Long term she also needs B12 monitoring, since the terminal ileum's role has changed.